Skip to content
cccskills
FreePublished on GitHub

esa-pa-pediatric-gluco-dose

Determines age- and body weight-appropriate glucocorticoid dosage for pediatric patients with primary aldosteronism, particularly glucocorticoid-remediable aldosteronism (GRA), to avoid over-treatment. Use when prescribing glucocorticoids to children with confirmed or suspected PA; triggers include pediatric PA, GRA, or need to dose glucocorticoid based on age and weight.

The English summary is being prepared. Showing the original description.

Run score Not tested

See how to install

Files included (1)

  • SKILL.md2.4 KB

SKILL.md (original)

Review the instructions the agent will receive before you install.

Calculate Glucocorticoid Dose for Children with PA

STEP 1 — Gather Information

Collect patient age, weight (kg), and confirm diagnosis of PA or suspected GRA. Verify that glucocorticoid therapy is indicated (e.g., glucocorticoid-remediable aldosteronism). Obtain baseline BP and potassium.

STEP 2 — Rule In / Rule Out

Is the patient a child (<18 years) with confirmed or suspected glucocorticoid-remediable aldosteronism (GRA) or PA requiring glucocorticoid? If yes, proceed; if no, do not use this skill.

STEP 3 — Classify or Stratify

Determine appropriate glucocorticoid (e.g., dexamethasone or prednisone) starting dose based on age and weight: For dexamethasone, 0.125–0.25 mg/day; for prednisone, 2.5–5 mg/day, administered at bedtime. Adjust dose to lowest effective amount that normalizes BP and/or serum potassium.

STEP 4 — Decide

Start with the lowest dose in the range, monitor BP and potassium, and titrate upward if needed to achieve normotension and normokalemia, avoiding signs of Cushingoid over-treatment. If BP fails to normalize with glucocorticoid alone, add an MR antagonist.

Clinical Guardrails / Mimics / Pitfalls

Avoid overtreatment that can cause iatrogenic Cushing’s syndrome and impaired linear growth in children. Do not exceed doses needed to normalize BP/potassium. Monitor for growth retardation, weight gain, hyperglycemia, and hypertension relapse. Do not use in patients without PA/GRA.

Concrete Clinical Example

A 10-year-old boy with hypertension and hypokalemia, diagnosed with GRA, weighs 30 kg. Start prednisone 2.5 mg at bedtime. After 2 weeks, BP 125/78 mm Hg, K+ 4.2 mmol/L; maintain dose. If BP remained 150/95, increase to 5 mg daily.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, https://doi.org/10.1210/jc.2015-4061

TODO: consider adding scripts/calc.py for the esa-pa-pediatric-gluco-dose calculator

Reviews

No reviews yet. Tell others what you thought.

Comments

No login needed. Share how it worked for you, ask a question, or note where it did not run.

No comments yet. Be the first to write one.

Comments are published right away. Do not include personal information such as email addresses or phone numbers. Up to 2 URLs.

0 / 1,000 characters

This form is protected by reCAPTCHA, and the Google Privacy Policy and Terms of Service apply.

More skills from this repository

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

The English summary is being prepared. Showing the original description.

dromlakhani/MD2SKILL14Updated Oct 20, 2026

See all skills by dromlakhani

Report a problem with this skill